Atomoxetine as an adjunct to nonpharmacological treatments for preventing vasovagal attacks in patients with recurrent vasovagal syncope: A pilot randomized-controlled trial
Background: Despite the reduced quality of life in patients with recurrent vasovagal syncope (VVS), pharmacologic treatment options remain limited. Studies indicate that norepinephrine reuptake inhibition reduces tilt-induced syncope/pre-syncope. This study aimed to evaluate the effects of atomoxeti...
Main Authors: | Masih Tajdini, Arya Aminorroaya, Hamed Tavolinejad, Saeed Tofighi, Arash Jalali, Saeed Sadeghian, Ali Vasheghani-Farahani, Somayeh Yadangi, Nazila Shahmansouri, Shahin Akhondzadeh, Ali Bozorgi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-06-01
|
Series: | International Journal of Cardiology: Heart & Vasculature |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352906721000774 |
Similar Items
-
Pacing for Vasovagal Syncope
by: Nevin T Wijesekera, et al.
Published: (2002-10-01) -
Vasovagal Syncope
by: Kress, Magdalena
Published: (2014) -
“Complex” Vasovagal Syncope: A Zebra Among Horses
by: Anwer Zohaib Siddiqi, et al.
Published: (2020-12-01) -
The Search for the Genes of Vasovagal Syncope
by: Robert S. Sheldon, et al.
Published: (2019-11-01) -
The role of Psychological Factors in the Aetiology and Treatment of Vasovagal Syncope
by: Jennifer Gracie, et al.
Published: (2004-04-01)